glucose, (beta-d)-isomer has been researched along with triazoles in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.55) | 18.7374 |
| 1990's | 6 (11.32) | 18.2507 |
| 2000's | 5 (9.43) | 29.6817 |
| 2010's | 38 (71.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggar, WD; Buron, S; Holmes, B | 1 |
| Dietzsch, B; Fischer, G; Valz, G; Wagner, G | 1 |
| Donigi-Gale, D; Edwards, R; Norman, KE; Rossi, AG; Shoupe, TS; Williams, TJ | 1 |
| Blom, M; Koenderman, L; Kok, PT; Roos, D; Tool, AT; Verhoeven, AJ | 1 |
| Benveniste, J; Bidault, J; Jurgens, P; Leyravaud, S; Ninio, E | 1 |
| Koenderman, L; Roos, D; Tool, AT; Verhoeven, AJ | 1 |
| Bozza, PT; Cordeiro, RS; Dias, PM; Faria Neto, HC; Lima, MC; Martins, MA; Silva, PM; Vargaftig, BB | 1 |
| Bourdon, V; Damas, J; Remacle-Volon, G | 1 |
| Hellewell, PG; Macari, DM; Teixeira, MM | 1 |
| Branch, RA; Carcillo, JA; Gillespie, DG; Jones, GS; Kochanek, PM; Korzekwa, KR; Kost, CK; Parise, RA; Whalen, MJ | 1 |
| Lee, LW; Lin, LH; Lin, PY; Sheu, SY | 1 |
| Abbas, AA; Khalil, NS | 1 |
| Camarero, S; Del Rio, JC; Gutiérrez, A; Ibarra, D; Martínez, AT; Martínez, MJ; Rencoret, J; Romero, J; Speranza, M | 1 |
| Khalil, NS | 2 |
| Bokor, E; Docsa, T; Gergely, P; Somsák, L | 1 |
| Boulton, DW; Griffen, SC; Kasichayanula, S; LaCreta, FP; Li, T; Liu, X; Pfister, M; Shyu, WC; Zhang, W | 1 |
| Hsu, CI; Hsu, MH; Huang, RC; Hwu, JR; Lee, YC; Liang, YC | 1 |
| Hu, AL; Lu, ML; Wu, HX; Xu, HH; Yang, W | 1 |
| Capuano, G; Nicolle, LE; Usiskin, K; Ways, K | 1 |
| Kadokura, T; Keirns, J; Krauwinkel, WJ; Smulders, RA; van Dijk, J; Veltkamp, SA; Zhang, W | 1 |
| Huang, T; Wu, HX; Xu, HH; Yang, W; Yao, GK; Zhang, ZX | 1 |
| Nyirjesy, P; Usiskin, K; Ways, K; Zhao, Y | 1 |
| Brand, T; Macha, S; Mattheus, M; Pinnetti, S; Woerle, HJ | 1 |
| Ebine, M; Genji, T; Inomata, S; Iwakura, I; Mukai, M; Shoji, M; Sugai, T; Tamura, S; Ueda, M | 1 |
| Bao, X; Ji, D; Li, J; Lu, B; Lu, J; Mu, J; Peng, C; Xin, C | 1 |
| Canovatchel, W; Fu, M; Gross, JL; Guarisco, M; Kawaguchi, M; Meininger, G; Rosenstock, J; Schernthaner, G; Yee, J | 1 |
| Loganathan, D; Srivastava, A | 1 |
| Johnson, MS | 1 |
| Canovatchel, W; Davidson, J; Januszewicz, A; Lavalle-González, FJ; Meininger, G; Qiu, R; Tong, C | 1 |
| Alba, M; Canovatchel, W; Cefalu, WT; Edwards, R; Jodar, E; Kim, KA; Meininger, G; Stenlöf, K; Tong, C | 1 |
| Hardy, E; Jabbour, SA; Parikh, S; Sugg, J | 1 |
| Berk, A; Broedl, UC; Ferrannini, E; Hach, T; Hantel, S; Pinnetti, S; Woerle, HJ | 1 |
| Anandhan, R; Rajakumar, P; Vadla, GP; Vellaichamy, E | 1 |
| Schnell, O | 1 |
| Bailey, RA; Blonde, L; Damaraju, CV; Martin, SC; Meininger, GE; Rupnow, MF | 1 |
| Forst, T; Goldenberg, R; Guthrie, R; Meininger, G; Stein, P; Vijapurkar, U; Yee, J | 1 |
| Lei, Z; Mao, G; Wang, J; Wen, Y; Xu, H | 1 |
| Ferrannini, E; Mari, A; Polidori, D | 1 |
| Scheen, AJ | 1 |
| Broedl, UC; Delafont, B; Eilbracht, J; Kim, G; Roden, M; Weng, J; Woerle, HJ | 1 |
| Guthrie, R; Slee, A; Traina, S | 1 |
| Doggrell, SA; Tuli, R | 1 |
| Jabbour, S | 1 |
| Doggrell, S | 1 |
| Cornell, S | 1 |
| Bailey, RA; Blonde, L; Meininger, GE; Rupnow, MF; Vijapurkar, U | 1 |
| Bailey, RA; Blonde, L; Meininger, G; Rupnow, MF; Vijapurkar, U | 1 |
| Andrade, SF; Carvalho, DT; Coelho, LF; de Souza, TB; Dias, AL; Dias, DF; Hipólito, TM; Ikegaki, M; Raimundo, PO; Rocha, RP; Silva, NC; Veloso, MP | 1 |
| Bokor, É; Docsa, T; Gergely, P; Somsák, L; Széles, Z | 1 |
| Abdul Razak, AR; Bartha-Vári, JH; Boros, Z; Cai, S; Carlson, R; Chong, YS; Chua, SY; Dagis, A; Feng, X; Foo, VH; Gabrail, NY; Gerecitano, JF; Gluckman, P; Huber, S; Ikram, MK; Irimie, FD; Kauffman, M; Kim, R; Kwek, K; Landesman, Y; Lassen, U; Li, D; Li, Q; Liu, C; Ma, J; Mahipal, A; Mau-Soerensen, M; McCauley, D; Mirza, MR; Nademanee, A; Ngo, C; Paizs, C; Palmer, JM; Pizzari, T; Poppe, L; Rashal, T; Saint-Martin, JR; Saw, SM; Shacham, S; Shields, AF; Stayner, LA; Tan, CS; Thorborg, K; Toşa, MI; Tsai, NC; Unger, TJ; Verkicharla, PK; Vértessy, BG; Wang, S; Wang, Y; Weiser, D; Wollin, M; Wong, TY; Xu, L; Yuan, L; Yuan, S; Zhang, Y; Zheng, R | 1 |
| Camodeca, C; Carbotti, G; Ciccone, L; Cuffaro, D; D'Andrea, F; Dive, V; Fabbi, M; Ferrini, S; Nencetti, S; Nuti, E; Orlandini, E; Rosalia, L; Rossello, A; Santamaria, S; Stura, EA; Tepshi, L | 1 |
| Bhaumik, I; Kundu, M; Misra, AK | 1 |
3 review(s) available for glucose, (beta-d)-isomer and triazoles
| Article | Year |
|---|---|
[Oral add-on therapy to metformin in type 2 diabetes mellitus: a direct comparison between canagliflozin and sitagliptin].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endpoint Determination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Thiophenes; Triazoles; Young Adult | 2014 |
Review of empagliflozin monotherapy for previously untreated patients with type 2 diabetes mellitus: Comparison with sitagliptin.
Topics: Adult; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Weight Loss | 2015 |
Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials.
Topics: Blood Pressure; Body Mass Index; Canagliflozin; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrazines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Thiophenes; Triazoles | 2015 |
17 trial(s) available for glucose, (beta-d)-isomer and triazoles
| Article | Year |
|---|---|
Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects.
Topics: Adolescent; Adult; Benzhydryl Compounds; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles; Young Adult | 2011 |
Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study.
Topics: Bacteriuria; Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycosuria; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triazoles; Urinary Tract Infections | 2012 |
No pharmacokinetic interaction between ipragliflozin and sitagliptin, pioglitazone, or glimepiride in healthy subjects.
Topics: Adolescent; Adult; Area Under Curve; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Interactions; Drug Therapy, Combination; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Thiophenes; Triazoles | 2012 |
Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor.
Topics: Antifungal Agents; Blood Glucose; Canagliflozin; Candida; Candidiasis, Vulvovaginal; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triazoles; Vagina | 2012 |
Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT-2) inhibitor, coadministered with sitagliptin in healthy volunteers.
Topics: Area Under Curve; Benzhydryl Compounds; Cross-Over Studies; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Glucosides; Humans; Hypoglycemic Agents; Male; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Triazoles | 2012 |
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial.
Topics: Aged; Blood Glucose; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiophenes; Treatment Outcome; Triazoles | 2013 |
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.
Topics: Adolescent; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Thiophenes; Treatment Outcome; Triazoles | 2013 |
Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.
Topics: Blood Glucose; Blood Pressure; Body Weight; Canagliflozin; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Double-Blind Method; Exercise; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Placebos; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome; Triazoles; Triglycerides; Weight Loss | 2014 |
Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.
Topics: Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Urinary Tract Infections; Weight Loss | 2014 |
Long-term safety and efficacy of empagliflozin, sitagliptin, and metformin: an active-controlled, parallel-group, randomized, 78-week open-label extension study in patients with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glucagon-Like Peptide 1; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Time Factors; Treatment Outcome; Triazoles | 2013 |
Attainment of diabetes-related quality measures with canagliflozin versus sitagliptin.
Topics: Aged; Blood Pressure; Body Mass Index; Canagliflozin; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pyrazines; Quality Indicators, Health Care; Racial Groups; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triazoles | 2014 |
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.
Topics: Blood Glucose; Blood Pressure; Canagliflozin; Candidiasis; Diabetes Mellitus, Type 2; Diuretics, Osmotic; Double-Blind Method; Drug Therapy, Combination; Female; Genital Diseases, Female; Genital Diseases, Male; Glucosides; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Pioglitazone; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Thiophenes; Treatment Outcome; Triazoles; Weight Loss | 2014 |
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Humans; Insulin-Secreting Cells; Least-Squares Analysis; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2; Sulfonylurea Compounds; Thiophenes; Time Factors; Triazoles | 2014 |
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.
Topics: Analysis of Variance; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Glucosides; Glycated Hemoglobin; Humans; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Triazoles | 2013 |
The impact of weight loss on weight-related quality of life and health satisfaction: results from a trial comparing canagliflozin with sitagliptin in triple therapy among people with type 2 diabetes.
Topics: Adult; Age Factors; Aged; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Health Behavior; Humans; Hypoglycemic Agents; Male; Middle Aged; Personal Satisfaction; Pyrazines; Quality of Life; Self Efficacy; Sex Factors; Sexual Behavior; Sitagliptin Phosphate; Thiophenes; Triazoles; Weight Loss | 2014 |
Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials.
Topics: Blood Pressure; Body Mass Index; Body Weight; Canagliflozin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Sitagliptin Phosphate; Thiophenes; Treatment Outcome; Triazoles | 2014 |
Topics: Active Transport, Cell Nucleus; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Benzhydryl Compounds; Benzylamines; Biopsy; Blood Glucose; Blood Transfusion; Cholesterol, LDL; Combined Modality Therapy; Cyclams; Diabetes Mellitus, Type 2; Disease Progression; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Glucosides; Glycated Hemoglobin; Granulocyte Colony-Stimulating Factor; Hamstring Muscles; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Hodgkin Disease; Humans; Hydrazines; Immunohistochemistry; Insulin-Secreting Cells; Leg; Male; Middle Aged; Muscle Strength; Neoplasms; Peripheral Blood Stem Cell Transplantation; Range of Motion, Articular; Recurrence; Remission Induction; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Soccer; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2 Inhibitors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Triazoles; Young Adult | 2015 |
33 other study(ies) available for glucose, (beta-d)-isomer and triazoles
| Article | Year |
|---|---|
Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms.
Topics: Animals; Cells, Cultured; Enterococcus faecalis; Hydrogen Peroxide; Iodine Radioisotopes; Macrophages; Nitrites; Peroxidases; Phagocytosis; Proteus mirabilis; Pulmonary Alveoli; Rabbits; Streptococcus pneumoniae; Tetrazolium Salts; Triazoles; Zymosan | 1976 |
[Glucosides of 7-hydroxy- and 7-mercapto-s-triazolo[1,5-a]pyrimidines. 53. Glycosides of heterocyclic compounds].
Topics: Acetylation; Glucosides; Glycosides; Pyrimidines; Spectrophotometry, Ultraviolet; Sulfhydryl Compounds; Triazoles | 1975 |
The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction.
Topics: Animals; Arthus Reaction; Azepines; Complement System Proteins; Edema; Isoquinolines; Leukotriene B4; Platelet Activating Factor; Rabbits; Radioimmunoassay; Receptors, Complement; Tetrazoles; Triazoles; Zymosan | 1992 |
Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles.
Topics: Azepines; Eosinophils; Humans; In Vitro Techniques; Kinetics; Oxygen Consumption; Phospholipases A; Platelet Activating Factor; Triazoles; Zymosan | 1992 |
Cell adhesion by membrane-bound paf-acether.
Topics: Animals; Azepines; Calcimycin; Cell Adhesion; Diterpenes; Ginkgolides; Humans; In Vitro Techniques; Lactones; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Triazoles; Zymosan | 1991 |
Platelet-activating factor (PAF) acts as an intercellular messenger in the changes of cytosolic free Ca2+ in human neutrophils induced by opsonized particles.
Topics: Azepines; Calcium; Cytosol; Humans; In Vitro Techniques; Neutrophils; Phagocytosis; Platelet Activating Factor; Signal Transduction; Triazines; Triazoles; Zymosan | 1989 |
Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.
Topics: Animals; Azepines; Carrageenan; Leukocyte Count; Male; Platelet Activating Factor; Pleurisy; Pyridines; Rats; Rats, Inbred Strains; Thiazoles; Triazines; Triazoles; Zymosan | 1989 |
Platelet-activating factor and the vascular effects of zymosan in rats.
Topics: Animals; Azepines; Blood Pressure; Capillary Permeability; Female; Hematocrit; Hemodynamics; Iodine Radioisotopes; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Rats; Rats, Wistar; Thiazoles; Thiazolidines; Triazoles; Zymosan | 1993 |
Priming of eosinophil recruitment in vivo by LPS pretreatment.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Azepines; CD18 Antigens; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Complement C5a, des-Arginine; Cycloheximide; Drug Synergism; Edema; Eosinophilia; Eosinophils; Female; Guinea Pigs; Immunoglobulin G; Interleukin 1 Receptor Antagonist Protein; Leukocyte Count; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Protein Synthesis Inhibitors; Pyrans; Quinolones; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sialoglycoproteins; Skin; Triazoles; Zymosan | 1996 |
The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.
Topics: Animals; Body Weight; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Enzyme Inhibitors; Inflammation; Leukocyte Count; Male; Microsomes, Liver; Neutrophils; Nitrates; Nitrites; Organ Size; Rats; Rats, Sprague-Dawley; Survival Analysis; Triazoles; Zymosan | 1998 |
Study on the stevioside analogues of steviolbioside, steviol, and isosteviol 19-alkyl amide dimers: synthesis and cytotoxic and antibacterial activity.
Topics: Amides; Amines; Anti-Bacterial Agents; Antineoplastic Agents; Bacillus subtilis; Cell Line, Tumor; Diterpenes, Kaurane; Escherichia coli; Glucosides; Humans; Microbial Sensitivity Tests; Organophosphorus Compounds; Pseudomonas aeruginosa; Structure-Activity Relationship; Triazoles | 2004 |
Synthesis of some new 1,3/ or 1,4-bis(glucopyranosyl-1,2,4-triazol-5-ylthio)propanes/ or butanes as potential antimicrobial agents.
Topics: Anti-Infective Agents; Bacillus subtilis; Biochemistry; Butanes; Candida albicans; Drug Evaluation, Preclinical; Escherichia coli; Glucosides; Microbial Sensitivity Tests; Propane; Pseudomonas aeruginosa; Staphylococcus aureus; Triazoles | 2005 |
Enzymatic removal of free and conjugated sterols forming pitch deposits in environmentally sound bleaching of eucalypt paper pulp.
Topics: Chromatography, Gas; Eucalyptus; Gas Chromatography-Mass Spectrometry; Glucosides; Industrial Microbiology; Industrial Waste; Laccase; Oxidation-Reduction; Oxygen; Paper; Sitosterols; Sterols; Triazoles; Water Purification | 2006 |
Efficient synthesis, structure, and antimicrobial activity of some novel N- and S-beta-D-glucosides of 5-pyridin-3-yl-1,2,4-triazoles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacillus subtilis; Candida albicans; Escherichia coli; Glucosides; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Triazoles | 2006 |
Novel simple efficient synthetic approach toward 6-substituted-2H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole-3-thiones and first synthesis and biological evaluation of N-and S-beta-D-glucosides of the[1,2,4]triazolo [3,4-b][1,3,4]thiadiazole ring system.
Topics: Anti-Infective Agents; Bacteria; Fungi; Glucosides; Microbial Sensitivity Tests; Thiadiazoles; Triazoles | 2007 |
Synthesis of 1-(D-glucopyranosyl)-1,2,3-triazoles and their evaluation as glycogen phosphorylase inhibitors.
Topics: Animals; Glucosides; Glycogen Phosphorylase, Muscle Form; Molecular Conformation; Rabbits; Structure-Activity Relationship; Triazoles | 2010 |
Glycosylated nordihydroguaiaretic acids as anti-cancer agents.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Galactosides; Glucosides; Glycosylation; Humans; Liver Neoplasms; Masoprocol; Triazoles | 2011 |
Synthesis of glucose-fipronil conjugate and its phloem mobility.
Topics: Animals; Glucose; Glucosides; Insecticides; Larva; Molecular Structure; Moths; Phloem; Pyrazoles; Ricinus communis; Triazoles | 2011 |
Uptake and phloem transport of glucose-fipronil conjugate in Ricinus communis involve a carrier-mediated mechanism.
Topics: Biological Transport; Cotyledon; Glucose; Glucosides; Insecticides; Models, Biological; Monosaccharide Transport Proteins; Phloem; Pyrazoles; Ricinus communis; Seedlings; Triazoles | 2012 |
Triazoyl-phenyl linker system enhancing the aqueous solubility of a molecular probe and its efficiency in affinity labeling of a target protein for jasmonate glucoside.
Topics: Affinity Labels; Cyclopentanes; Glucosides; Hydrophobic and Hydrophilic Interactions; Molecular Conformation; Molecular Probes; Oxylipins; Proteins; Solubility; Triazoles; Water | 2013 |
Efficient synthesis and antimicrobial activity of some novel S-β-d-glucosides of 5-aryl-1,2,4-triazole-3-thiones derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Escherichia coli; Glucosides; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Thiones; Triazoles | 2013 |
Synthesis of guanidino sugar conjugates as GlcβArg analogs.
Topics: Acetamides; Arginine; Carbohydrates; Glucosides; Guanidine; Triazoles | 2013 |
The top 10 drug trends right now.
Topics: Ado-Trastuzumab Emtansine; Antibodies, Monoclonal, Humanized; Azepines; Biphenyl Compounds; Canagliflozin; Cholesterol Ester Transfer Proteins; Dimethyl Fumarate; Drug Approval; Forecasting; Fumarates; gamma-Cyclodextrins; Glucosides; Humans; Lactones; Maytansine; Pyridines; Sofosbuvir; Sugammadex; Thiophenes; Trastuzumab; Triazoles; United States; United States Food and Drug Administration; Uridine Monophosphate | 2013 |
Synthesis and cardio protective biological applications of glucodendrimers by H9C2 cell studies.
Topics: Animals; Cardiotonic Agents; Cell Line; Cell Survival; Dendrimers; Gene Expression; Glucose; Glucosides; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocytes, Cardiac; Rats; Structure-Activity Relationship; Triazoles | 2014 |
Phloem mobility and translocation of fluorescent conjugate containing glucose and NBD in castor bean (Ricinus communis).
Topics: Chromatography, High Pressure Liquid; Cotyledon; Fluorescent Dyes; Glucose; Glucosides; Microscopy, Fluorescence; Oxadiazoles; Phloem; Ricinus; Tandem Mass Spectrometry; Time Factors; Triazoles | 2014 |
SGLT2 versus DPP4 inhibitors for type 2 diabetes.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Male; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Triazoles | 2013 |
Dapagliflozin--do we need it registered for type 2 diabetes?
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Metformin; Pyrazines; Triazoles | 2014 |
Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes?
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Metformin; Pyrazines; Triazoles | 2014 |
Author’s response.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Metformin; Pyrazines; Triazoles | 2014 |
Synthesis and antimicrobial activity of 6-triazolo-6-deoxy eugenol glucosides.
Topics: Anti-Infective Agents; Eugenol; Glucosides; Inhibitory Concentration 50; Micrococcus luteus; Salmonella typhimurium; Triazoles | 2015 |
C-Glucopyranosyl-1,2,4-triazol-5-ones: synthesis and inhibition of glycogen phosphorylase.
Topics: Animals; Boronic Acids; Enzyme Assays; Enzyme Inhibitors; Glucose; Glucosides; Glycogen Phosphorylase; Kinetics; Muscle, Skeletal; Naphthalenes; Rabbits; Triazoles | 2016 |
Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors.
Topics: Acetylglucosamine; Catalytic Domain; Glucosides; Humans; Matrix Metalloproteinase 12; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Solubility; Sulfonamides; Thiourea; Triazoles; Water | 2016 |
Organocatalyzed preparation of 1,4,5-trisubstituted-glycosyl-1,2,3-triazole derivatives.
Topics: Azides; Catalysis; Chemistry Techniques, Synthetic; Chemistry, Pharmaceutical; Cycloaddition Reaction; Glucosides; Humans; Ketones; Molecular Structure; Triazoles | 2019 |